BRPI0719689A2 - Composição co0ntendo derivado de aurona para diagnose - Google Patents
Composição co0ntendo derivado de aurona para diagnoseInfo
- Publication number
- BRPI0719689A2 BRPI0719689A2 BRPI0719689-0A2A BRPI0719689A BRPI0719689A2 BR PI0719689 A2 BRPI0719689 A2 BR PI0719689A2 BR PI0719689 A BRPI0719689 A BR PI0719689A BR PI0719689 A2 BRPI0719689 A2 BR PI0719689A2
- Authority
- BR
- Brazil
- Prior art keywords
- aurona
- diagnosis
- derivative
- composition containing
- composition
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/0412—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K51/0419—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006328131 | 2006-12-05 | ||
| JP2007081602 | 2007-03-27 | ||
| PCT/JP2007/070930 WO2008068974A1 (ja) | 2006-12-05 | 2007-10-26 | オーロン誘導体含有診断用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0719689A2 true BRPI0719689A2 (pt) | 2013-12-24 |
Family
ID=39491885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0719689-0A2A BRPI0719689A2 (pt) | 2006-12-05 | 2007-10-26 | Composição co0ntendo derivado de aurona para diagnose |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100003191A1 (pt) |
| EP (1) | EP2113258A1 (pt) |
| JP (1) | JPWO2008068974A1 (pt) |
| KR (1) | KR20090087037A (pt) |
| AU (1) | AU2007330190A1 (pt) |
| BR (1) | BRPI0719689A2 (pt) |
| CA (1) | CA2671596A1 (pt) |
| IL (1) | IL198918A0 (pt) |
| MX (1) | MX2009006003A (pt) |
| RU (1) | RU2009125612A (pt) |
| WO (1) | WO2008068974A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8193363B2 (en) * | 2008-08-29 | 2012-06-05 | Astrazeneca Ab | Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits |
| MX372914B (es) | 2015-06-16 | 2020-04-27 | Jiangsu Hengrui Medicine Co | Derivado de piperidina y metodo de preparacion y uso farmaceutico del mismo. |
| US10899727B2 (en) | 2016-04-11 | 2021-01-26 | Middle Tennessee State University | Therapeutic aurones |
| MX2020009372A (es) | 2018-03-09 | 2020-10-14 | Recurium Ip Holdings Llc | 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-onas sustituidas. |
| JP7204568B2 (ja) * | 2018-04-04 | 2023-01-16 | 株式会社Cics | アミロイドβ疾患のホウ素中性子捕捉療法用化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0130305D0 (en) * | 2001-12-19 | 2002-02-06 | Amersham Plc | Compounds for imaging alzheimers disease |
| CN100537559C (zh) * | 2006-06-14 | 2009-09-09 | 浙江大学 | 类黄酮衍生物及其制备方法和用途 |
-
2007
- 2007-10-26 KR KR1020097011572A patent/KR20090087037A/ko not_active Withdrawn
- 2007-10-26 EP EP07830664A patent/EP2113258A1/en not_active Withdrawn
- 2007-10-26 US US12/517,159 patent/US20100003191A1/en not_active Abandoned
- 2007-10-26 CA CA002671596A patent/CA2671596A1/en not_active Abandoned
- 2007-10-26 WO PCT/JP2007/070930 patent/WO2008068974A1/ja not_active Ceased
- 2007-10-26 AU AU2007330190A patent/AU2007330190A1/en not_active Abandoned
- 2007-10-26 MX MX2009006003A patent/MX2009006003A/es not_active Application Discontinuation
- 2007-10-26 JP JP2008548198A patent/JPWO2008068974A1/ja active Pending
- 2007-10-26 BR BRPI0719689-0A2A patent/BRPI0719689A2/pt not_active IP Right Cessation
- 2007-10-26 RU RU2009125612/15A patent/RU2009125612A/ru not_active Application Discontinuation
-
2009
- 2009-05-25 IL IL198918A patent/IL198918A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2113258A1 (en) | 2009-11-04 |
| US20100003191A1 (en) | 2010-01-07 |
| MX2009006003A (es) | 2009-06-17 |
| RU2009125612A (ru) | 2011-01-20 |
| KR20090087037A (ko) | 2009-08-14 |
| CA2671596A1 (en) | 2008-12-06 |
| JPWO2008068974A1 (ja) | 2010-03-18 |
| AU2007330190A1 (en) | 2008-06-12 |
| WO2008068974A1 (ja) | 2008-06-12 |
| IL198918A0 (en) | 2011-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2053117A4 (en) | LUBRICANT COMPOSITION | |
| BRPI0716325A2 (pt) | Composição antimicrobianas | |
| EP2180018A4 (en) | POLYAMIDE COMPOSITION | |
| PT2596784T (pt) | Composições de tapentadol | |
| BRPI0722082A2 (pt) | Ligantes para imagiologia da inervação cardíaca | |
| IL195271A0 (en) | Composition for diagnosing amyloid-related disease | |
| BRPI0818349A2 (pt) | Dispositivo de reconstrução | |
| BRPI0818079A2 (pt) | composição de lipideo | |
| EP2166074A4 (en) | CLEANING SUPPLIES | |
| DE602007014320D1 (de) | Untersetzungsgetriebe | |
| EP2003187A4 (en) | LUBRICANT COMPOSITIONS | |
| EP2072519A4 (en) | DIARYLKETIMINDERIVAT | |
| EP2223992A4 (en) | LUBRICANT COMPOSITION | |
| EP2043136A4 (en) | FILMING COMPOSITION | |
| EP2119761A4 (en) | LUBRICANT COMPOSITION | |
| EP2141220A4 (en) | LUBRICANT COMPOSITIONS | |
| BRPI0716458A2 (pt) | Composição de vulcanizado | |
| BRPI0815246A2 (pt) | Composição de catalisador | |
| BRPI0820885A2 (pt) | Composições e métodos para diagnóstico precoce de gravidez | |
| BRPI0718428A2 (pt) | Composição de ibuprofeno | |
| FR2899479B1 (fr) | Composition cicatrisante | |
| EP2144635A4 (en) | STERILIZING COMPOSITION | |
| EP2154231A4 (en) | LUBRICANT COMPOSITION | |
| EP2197828A4 (en) | FULLEREN-MULTIADDUKT COMPOSITION | |
| BRPI0718141A2 (pt) | Composições de frangrâncias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A, 6A E 7A ANUIDADES. |
|
| B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |